Island Pharmaceuticals: Developing a new drug for a disease that 400m people are diagnosed with a year – now that’s scalable!

Listen to ASX-listed Island Pharmaceuticals Managing Director Dr David Foster talk to Matt Birney on the Bulls N’ Bears Report about Island Pharmaceuticals’ remarkable redevelopment of a drug that was once created to tackle an entirely different disease.